Skip to content

Clinical efficacy and mechanism study of non-invasive brain stimulation technology for post-stroke dysphagia

Clinical efficacy and mechanism study of non-invasive brain stimulation technology for post-stroke dysphagia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082125
Enrollment
Unknown
Registered
2024-03-21
Start date
2024-03-21
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

rTMS treatment group:Patients in all 3 groups received traditional swallowing function training by the same experienced and competent therapist. On this basis, rTMS stimulation group: bilateral suprag
tDCS treatment group:Patients in all 3 groups received traditional swallowing function training by the same experienced and competent therapist. On this basis, tDCS stimulation group: bilateral suprag
Combination therapy group:Patients in all 3 groups received traditional swallowing function training by the same experienced and competent therapist. On this basis, the combined treatment group: bilat

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Compliant with the diagnostic criteria for various cerebrovascular diseases revised by the Fourth National Conference on Cerebrovascular Diseases of the Chinese Medical Association, and confirmed by cranial CT or MRI as cerebral hemorrhage or cerebral infarction. (2) Age range from 40 to 80 years old. (3) Medical history = 3 months. (4) Swallowing disorders persist for = 2 weeks after stroke. (5) The X-ray examination of swallowing confirms the presence of abnormal manifestations in terms of swallowing safety or effectiveness. (6) Clear awareness, stable condition, able to maintain sitting balance independently or with assistance for more than 30 minutes. (7) The patient or family member agrees and voluntarily signs the informed consent form for this clinical study.

Exclusion criteria

Exclusion criteria: (1) Merge other diseases that may cause swallowing disorders, such as Parkinson's disease, dementia, motor neuron disease, and other neurological diseases, or diseases that cause structural abnormalities in the swallowing organs with laryngectomy, esophageal surgery, and other complications. (2) Accompanied by a history of epileptic seizures, implantation of pacemakers or drug pumps in the body, skull defects, skull metal implants, late stage malignant tumors, pregnancy, etc. (3) Surface electrode placement may be affected by scalp, orbital, and anterior cervical skin rupture, infection, and other factors.

Design outcomes

Primary

MeasureTime frame
Functional Dysphagia Scale;Dysphagia Outcome and Severity Scale;Activation of relevant brain regions during swallowing tasks;

Secondary

MeasureTime frame
Swallowing related quality of life scale;Latency and amplitude of motor evoked potentials;The root mean square value of the suprahyoid muscle group;

Countries

China

Contacts

Public ContactChengqi He

West China Hospital of Sichuan University

hxkfhcq@126.com+86 181 8046 9098

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026